Table 5. Projected costs and distribution of costs of increasing the coverage of traditional and underused vaccines and health systems requirements to reach the GIVS goals by 2015 in 72 GAVI Alliance-eligible countries, together with funding gaps.
| Costing 2006–2015 | AFR (US$ millions) | AMR (US$ millions) | EMR (US$ millions) | EUR (US$ millions) | SEAR (US$ millions) | WPR (US$ millions) | Total (US$ millions) |
|---|---|---|---|---|---|---|---|
| Vaccines | 4 621 | 214 | 1 301 | 342 | 5 400 | 559 | 12 438 |
| Traditional | 19% | 15% | 22% | 14% | 21% | 15% | 20% |
| Underused | 53% | 46% | 49% | 48% | 38% | 51% | 46% |
| New | 28% | 39% | 30% | 38% | 41% | 34% | 35% |
| Systems | 6 537 | 666 | 1 790 | 608 | 9 957 | 1 318 | 20 875 |
| Maintaining system | 70% | 77% | 50% | 74% | 82% | 53% | 73% |
| Scaling up | 1 978 | 150 | 894 | 158 | 1 819 | 615 | 5 615 |
| Cold chain | 25% | 21% | 16% | 29% | 27% | 11% | 23% |
| Training & supervision | 6% | 31% | 6% | 44% | 21% | 8% | 13% |
| Vehicles and transport | 18% | 11% | 20% | 9% | 7% | 8% | 13% |
| Social mobilization | 12% | 13% | 13% | 1% | 7% | 3% | 9% |
| Surveillance, M&E | 15% | 10% | 18% | 9% | 9% | 4% | 12% |
| Waste management | 2% | 1% | 1% | 1% | 2% | 1% | 2% |
| Personnel | 17% | 9% | 22% | 2% | 23% | 63% | 24% |
| Overheads | 5% | 5% | 4% | 5% | 5% | 2% | 4% |
| Campaigns | 875 | 12 | 303 | 3 | 970 | 22 | 2 184 |
| TOTAL | 12 033 | 892 | 3 393 | 953 | 16 327 | 1 899 | 35 496 |
|
% of costs by region |
33.9% |
2.5% |
9.6% |
2.7% |
46.0% |
5.3% |
100.0% |
| Probable funding gapsa | 17% | 28% | 42% | 32% | 33% | 36% | 28% |
| Vaccines | 31% | 46% | 52% | 52% | 64% | 38% | 49% |
| Systems | 2% | 21% | 31% | 20% | 14% | 35% | 13% |
| Campaigns | 55% | 71% | 62% | 97% | 51% | 65% | 54% |
| Total funding gap (in millions of US$) | 2 019 | 246 | 1 418 | 301 | 5 364 | 687 | 10 036 |
| % of funding gap by region | 20% | 2% | 14% | 3% | 53% | 7% | 100% |
AFR, WHO African Region; AMR, WHO Region of the Americas; EMR, WHO Eastern Mediterranean Region; EUR, WHO European Region; SEAR, WHO South-East Asia Region; WPR, WHO Western Pacific Region; M & E, monitoring and evaluation. a Source of data on funding gaps: Assumes an optimistic funding scenario based on: (a) extrapolating the amounts national governments and external donors will contribute to immunization between 2006 and 2015 from the Financial Sustainability Plans19 and reported data on immunization financing18 (assuming that they will fund in the future at least as much as in the past); (b) taking funding scenarios provided by the GAVI Secretariat (as known in December 2005; optimistic expenditure scenario of approximately US$ 5.8 billion); (c) using the funding estimates for campaigns made by the WHO Polio Team and the Measles,45 Tetanus46 and Yellow Fever47 groups in GAVI Alliance investment cases.